ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
31 Jul 2017 01:45

Recap on Celltrion Healthcare IPO Day - Retail Investors Turned Positive, Why?

Celltrion Healthcare (091990 KS)'s performance on its market debut day was a bit of a surprise. Of course, given that the IPO price was set at the...

Logo
163 Views
Share
25 Jul 2017 21:50

Biogen Likes Biosimilars

Biogen Inc (BIIB US) , the partner of Samsung Biologics Co., Ltd (207940 KS) in the Samsung Bioepis JV, reported Q2 2017 results this morning and...

Share
bearishCelltrion Inc
19 Jul 2017 06:14

JNJ's REMICADE Holds: PFE's Results To Confirm

Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...

Share
13 Jul 2017 11:26

Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics

Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...

Share
12 Jul 2017 13:51

Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate

Celltrion Healthcare (091990 KS)'s bookbuilding is now in progress among overseas investors, and local bookbuilding will begin tomorrow and end on...

Logo
268 Views
Share
x